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In female mammals, one of the two X chromosomes is inactivated
to maintain equal expression between sexes by a process called X
chromosome inactivation (XCI) [1]. XCI is a complex and tightly
regulated mechanism governed by the XIST gene which encodes a
non-coding functional RNA coating the chromosome from which it is
expressed and triggers inactivation [2]. Although most genes are
silenced by this process, it has long been recognized that some genes
escape XCI and are expressed from both the active X (Xa) and inactive
X (Xi) chromosomes. Studies using rodent-human hybrid cell lines
retaining an inactive human X chromosome have estimated that
about 25% of X-linked genes escape inactivation to some degree [3–5].The exact mechanisms regulating expression status of genes on the
inactive X are not fully elucidated. It is known that genes escaping
inactivation are not uniformly distributed along the X chromosome
but preferentially lie in the evolutionary younger strata of the X
chromosome [5,6]. It has been hypothesized that long interspersed
elements (LINE-1), which are particularly abundant on the X
chromosome and are enriched in the vicinity of inactivated genes,
might control spreading of XCI [7,8].
Although in vitro hybrid systems have greatly contributed to our
knowledge of XCI, they do not reﬂect the in vivo processes. In
particular, these experiments do not quantify the difference of
expression between males and females for genes that escape
inactivation. These genes are of primary interest since they are
potential contributors to variability between sexes for phenotypic and
clinical traits. Recent studies have taken beneﬁt from the microarray
technology to compare expression proﬁles of the X chromosome
between males and females [9–12]. The largest study, based on
lymphoblastoid cell lines (LCLs) from 210 individuals from the four
HapMap populations, reported 5% of X-linked genes showing higher
expression in females than inmales [9], a proportionmuch lower than
the 25% of genes previously thought to escape XCI [5,6]. This
underestimation might be partly explained by an insufﬁcient power
to detect small sex differences, since expression from the inactive
chromosome may be low or present only in a fraction of females [5].
Here, we report the results of a large-scale study including 1467
population-based subjects in whom the expression proﬁle from
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extent the mechanism of XCI was supported by this dataset including
715 X-linked transcripts. Secondly, because the impact of X-linked
genetic variability on expressionmay have profound consequences on
disease traits, as attested by numerous X-linked diseases, we
investigated whether cis expression quantitative loci (eQTLs) on the
X chromosome differed between sexes.2. Results
The study was conducted in 717 women and 750 men of European
origin aged 35 to 74 years that were recruited in the Gutenberg Heart
Study (GHS), a community-based project conducted in a single centre
in Germany [13]. Genome-wide expression proﬁles of peripheral
blood monocytes were generated using Illumina HT-12 BeadChip
expression arrays and genome-wide genotyping was performed using
the Affymetrix Genome-Wide Human SNP Array 6.0.2.1. X-linked transcripts detected in human monocytes
After removing probes with a bad quality score, 1156 probes were
unambiguously assigned to theX chromosome, corresponding to 706X-
linked genes. Analyses were performed at the probe level and, for
simplicity, the term of “transcript”was used to denote a unique probe-
hybridization product (although in few cases the same transcript could
be targeted by several probes). We focused on transcripts whose
expression was detected, i.e. higher than the background signal, in≥5%
of female samples or≥5% of male samples. These represented 715 X-
linked (61.8%) transcripts corresponding to 503 unique genes (Supple-
mentary Table 1). The majority of X-linked transcripts were detected
with similar detection rates in males and females (Supplementary Fig.
1). XIST (X (inactive)-speciﬁc transcript), the gene responsible for
inactivation of one of the X copies in females, was expressed at low
levels, yet higher than the background signal, in 62% of males.Fig. 1. Comparison of expression levels of X-linked transcripts between males and females. (A
completely escape XCI in females (log2Y=log2X+1). The only point departing from this
(B) Variance of expression.2.2. Expression level of X-linked transcripts according to sex
For each of the 715 X-linked transcripts, the median and the
variance of expression levels in males were plotted against those in
females (Fig. 1). Most of the data points lay on the diagonal
suggesting that XCI was globally achieved for the majority of
genes. There were however a few points departing from the
diagonal, most of them showing a higher expression level in
females than in males.
We then focused on the transcripts that were differentially
expressed between sexes using a Bonferroni-corrected signiﬁcance
threshold to account for the number of transcripts tested (7.0×10−5).
We distinguished transcripts that were expressed at a higher level in
females (referred to as female-biased) from those that were
expressed at a higher level in males (male-biased) [14]. We observed
a higher proportion of female-biased than male-biased X-linked
transcripts (9.37% vs 5.59%, p=0.006). We tested whether these
proportions were different from those observed on autosomes by
resampling 106 sets of 715 autosomal transcripts. There was a
signiﬁcant excess of female-biased transcripts on the X chromosome
compared to autosomes (9.37% vs 5.46%, pb2×10−5) whereas the
difference was not signiﬁcant for male-biased transcripts (5.59% vs
4.65%, p=0.10). The higher proportion of female-biased genes is in
agreementwith the fact that a fraction of X-linked genes are known or
suspected to escape from silencing [5,9–12].
Because the method of monocyte enrichment used in the present
study did not yield a 100% purity and even modest heterogeneity of
cell content may induce artefactual associations, we checked whether
contamination by non-monocyte cells might affect the differences
observed. To estimate the relative amount of RNA coming from the
different blood cell types, we applied a deconvolution algorithm
proposed in [15] and used cell-speciﬁc expression proﬁles reported in
the HaemAtlas [16] to generate surrogate variables of contamination
(see Methods). Adjusting for these variables hardly modiﬁed the
difference between female-biased and male-biased X-linked genes
(9.51% vs 5.73%, p=0.007).) Median of expression. The pink line represents the situation where transcripts would
line is XIST, the gene responsible for X inactivation of one chromosome in females.
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genes (40 transcripts) of the X chromosome are listed in Supplementary
Table 2. After adjustment for covariates (age, body mass index and
smoking) or exclusion of women with oral contraception or hormone
replacement therapy, only a few genes lost signiﬁcance, suggesting that
the classical risk factors did not explain the majority of the sex-biased
expressions (Supplementary Table 2). Sex explained a much higher
proportion of the inter-individual variability of expression in female-
biased than in male-biased genes: in 20 of the 54 female-biased genes,
the R2 attributable to sexwas higher than 5%whereas it never exceeded
this threshold in male-biased genes. About half of the genes found to be
female-biased inour studyhadbeenpreviously reported to escapeXCI to
some degree [5]. Among the genes not previously known to escape XCI,
EFHC2 (EF-hand domain (C terminal)-containing protein 2) was the
most differentially expressed between males and females, with sex
explaining almost 20% of the inter-individual variability of expression.
Among the 35 male-biased genes, ﬁve had been previously reported to
escapeXCI to somedegree [5]. Twoof them,HCFC1 andMAGEE1, wereno
longer differentially expressed after adjustment for covariates (Supple-
mentary Table 2). By contrast, expression levels of SH3KBP1, USP11 and
RBBP7 remained signiﬁcantly higher in males, suggesting that these
genes, even though they escape XCI to some extent, do not achieve full
compensation in females. Higher levels in males might be explained by
sex-inﬂuenced hormonal control not accounted for by the covariates.
We compared our results with those reported in LCLs from the four
HapMap populations [9]. To get robust comparison, we selected the
genes that were differentially expressed (pb0.001) in at least three
populations. No gene was reported as male-biased in LCLs, except
CD99 which is actually located in the PAR1 pseudo-autosomal region
(see below). Among the 13 genes that were found female-biased in
LCLs, all except two (FUNDC1 and USP9X) were also found female-
biased in monocytes (Supplementary Table 2). By contrast we found
43 female-biased genes in monocytes that were not reported in LCLs.
The higher number of sex-biased genes in monocytes might be partly
attributable to tissue-speciﬁcity of gene expression or different
inﬂuence of sex hormones, but it is also likely a consequence of the
greater sample size of the present study.
2.3. Expression of genes of the pseudo-autosomal regions (PARs)
At both ends of the X chromosome, the PARs are regions of XY
recombination where genes are essentially equivalent on the X and YFig. 2.Difference of expression levels between females andmales according to the position of
to S5 represent strata that ceased to recombine with the Y chromosome at different times o
pink dots and male-biased transcripts by blue dots.chromosomes. For genes lying in PARs, escape from XCI is thought to
be necessary for dosage compensation between the two female X
chromosomes and the male X and Y. Of the 33 transcripts of the
expression array belonging to PARs, 22 were detected in monocytes
corresponding to 14 unique genes, among which 8 had been
previously reported to escape XCI [5]. In the present study, ﬁve PAR
genes (35.7%)were found to bemale-biased (DHRSX (dehydrogenase/
reductase SDR family X-linked), P2RY8 (purinergic receptor P2Y G-
protein coupled 8), PLCXD1 (phosphatidylinositol-speciﬁc phospho-
lipase C, X domain containing 1), CD99 (CD99 antigen) and CSF2RA
(colony stimulating factor 2 receptor, alpha, low-afﬁnity) (Supple-
mentary Table 3). The proportion of male-biased genes in PARs found
here is higher than previously reported [9,17], probably owing to the
greater power of the present study. Unlike the conclusion drawn from
a smaller study in LCLs [9], our study does not support the notion that
the majority of PAR genes are fully dosage compensated in females.
The lower expression levels in females could be explained by a partial
silencing of the genes on the Xi copy or by an upregulation on the Y
copy.
2.4. Distribution of sex-biased genes on the X chromosome
As previously reported [5,9,12], female-biased genes were not
uniformly distributed along the X chromosome but preferentially
clustered on the short arm (16.1% of the transcripts lying on the short
arm were female-biased versus 6.3% on the long arm, p=3.0×10−4),
more speciﬁcally in regions that more recently stopped recombining
with the Y chromosome (strata S3 to S5) (Fig. 2). PAR1 was the region
the most enriched in male-biased genes. Although an enrichment in
male-biased genes has been reported in stratum 3 compared to strata
1 and 2 [17], the present data did not support such an evidence.
2.5. Identiﬁcation of cis eQTLs on the X chromosome
The total number of SNPs locatedwithin a 250 kb interval of any X-
linked gene (referred to as cis SNPs) was 15,703. After exclusion of
transcripts probed by polymorphic sequences (n=89) and tran-
scripts having no cis SNP (n=11), 615 X-linked transcripts (456
unique genes) were included in the analysis of cis eQTLs. The median
number of cis SNPs per gene was 41 (interquartile range: 16–85).
Association between SNP and expression was tested assuming an
additive model. Given the speciﬁcity of the X chromosome withtranscripts on the X chromosome. PAR1 and PAR2 are the pseudo-autosomal regions. S1
f evolutionary history (S1 is the most ancient). Female-biased transcripts are shown by
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of eQTLs on the X chromosome is complicated by the fact that, for a
same allele effect, the variance explained by a SNP under an additive
model is expected to be twice lower in females than in males due to
the different number of X copies (see Appendix). For genes escaping
XCI, this assumptionmay not hold but these represent only a minority
of X-linked genes. As a consequence, the power to detect cis
associations is lower in females than in males for a same sample
size. To circumvent this problem, we used the R2 (proportion of
variance explained by a SNP) rather than the p-value to compare the
frequency of cis eQTLs between males and females, after multiplying
the female R2 by a correction factor to account for the difference of
variances between sexes. Assuming that residual variances are equal
in both sexes (a reasonable assumption according to Fig. 1), the
correction factor in females is equal to 2/(R2XF+1) where R2XF is the
R2 explained by an X-linked SNP in females (see Appendix).
All associations with an R2N5% in either sex were considered. This
corresponded to taking a signiﬁcance threshold of 5.8×10−10 in
males and 9.9×10−5 in females (or a R2XFN2.56% in females before
correction). Using this threshold, 71 transcripts were associated with
a cis SNP in females (11.5% of the 615 X-linked transcripts) and 56
(9.1%) inmales. For genes represented by several SNP-transcript pairs,
we retained the SNP-transcript pair associated with the highest R2.
This resulted in 60 (13.2%) and 48 (10.5%) X-linked genes that were
cis regulated in females and males, respectively (p=0.21).
In order to compare cis eQTLs inmales and females, we retained for
each expression trait the SNP having the smallest combined p-value of
association when combining males and females. Among the 64 cis
eQTLs detected on the X chromosome, 44were common to both sexes,
16 were female-speciﬁc and 4 were male-speciﬁc (Supplementary
Table 4). The R2 of cis eQTLs was roughly comparable in males and
females (Fig. 3 and Supplementary Table 4) and allele effects were in
the same direction in males and females. Six genes hadmore than 25%
of the variability of their expression explained by cis regulation in
both sexes (ranked by combined p-value: GPR34 (G protein-coupled
receptor 34), TMEM187 (transmembrane protein 187), ARSD (aryl-
sulfatase D), MAOA (monoamine oxidase A), CHST7 (carbohydrate N-
acetylglucosamine 6-O sulfotransferase 7) and GPM6B (glycoproteinFig. 3. Cis eQTLs of the X chromosome: proportion of variability of expression (R2)
explained by the best cis SNP in males and in females. Cis eQTLs associated with an
R2N5% in either gender were selected (see Supplementary Table 4).M6B ). In females, departure from the hypothesis of additivity was
tested but never reached signiﬁcance.
To further identify cis eQTLs that were differentially regulated in
males and females, we modeled expression as a function of sex,
genotype and the interaction between sex and genotype. When
correcting for the number of genes tested, four genes exhibited a
signiﬁcant interaction with sex (pb8×10−5): ARSD, DCX (doublecor-
tin), POLA1 (DNA polymerase alpha 1 catalytic subunit) and ITM2A
(integral protein membrane 2A). Two additional genes, OCRL
(responsible of the oculocerebrorenal syndrome of Lowe) and PLS3
(plastin3), showed suggestive evidence for sex interaction (pb10−3)
(Supplementary Table 4). In all cases except ARSD, the cis regulatory
effect was signiﬁcant only in females. For ARSD, the cis effect was
observed in both sexes but the allele effect of rs211653 on expression
was more marked in females than in males (β=−0.114±0.008 vs
−0.076±0.005, p=1.2×10−5) and after correction, the SNP
explained 37.0% of the variability of ARSD expression in females
versus 26.3% in males (Fig. 4).3. Discussion
In the present study, we found that nearly 10% of X-linked genes
were female-biased, a proportion higher than previously reported in
smaller microarray-based studies [9–12]. Female-biased genes were
more frequent on the X chromosome than on autosomes, a ﬁnding
consistent with the feminization of the X chromosome during
mammalian evolution [17]. Most of the genes previously known or
suspected to escape XCI had a female-biased expression in our study.
In addition to the genes already known, we identiﬁed several new
genes that were associated with higher expression in females. For
most of them, the difference between sexes was relatively small,
suggesting that expression from the Xi copy was reduced compared to
that from the Xa copy, or that escape from XCI occurred only in a
fraction of females as previously suggested [5]. On the other hand, an
alternative explanation for the higher female expression could be thatFig. 4. Box plots of ARSD expression levels according to rs211653 genotype and sex.
Numbers of subjects in each genotype are indicated on the left of the box plots.
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compared to themale X chromosome, due to sex inﬂuenced hormonal
control or to environmental factors. For these newly identiﬁed genes,
the exactmechanism explaining the over-expression in femalesmight
be studied using a cell-hybrid assay system that compares expression
between the Xa and the Xi female chromosomes or between the
female Xa chromosome and the male X chromosome.
Among the new female-biased genes, EFHC2 deserves special
attention as almost 20% of expression variability of this gene was
explained by sex. EFHC2 is located at Xp11.3 close to a locus
implicated in Turner syndrome, a sporadic disorder of women in
which all or part of one chromosome X is deleted [18]. This locus is
known to be subject to maternal imprinting and X inactivation [18]
and the higher female expression of EFHC2 in the present study
suggests that the region submitted to XCI and imprinting might
extend up to EFHC2. The EFHC2 gene has been suspected to be
involved in fear recognition in women with Turner syndrome [19]
although this ﬁnding has not been further conﬁrmed [20].
The proportion of X-linked male-biased genes was lower than that
of female-biased genes and was not different from the proportion
observed on autosomes. As recently suggested by the evolutionary
history of the mammalian X chromosome, X-linked male-biased
genes would be younger genes whereas their autosomal counterparts
would be older genes [17]. This is consistent with a progressive
demasculinization of the X chromosome duringmammalian evolution
and the out-of-X trafﬁc of male-biased genes resulting in an
enrichment of these genes on autosomes in the long term [17]. It
would be interesting to test this hypothesis by dating the sex-biased
genes found in the present study.
Despite a growing interest for the genetics of gene expression in
recent years [21], little is known about the consequence of the allele
dosage imbalance of X-linked SNPs on expression. For loci that are
subject to XCI in females, which are the vast majority as seen above,
the proportion of variance attributable to X-linked SNPs is expected to
be lower in females than inmales [22]. To restore the balance between
sexes, we derived and applied a correction factor to the female R2.
After this correction, the magnitude of most cis eQTLs appeared
remarkably similar in both sexes. The frequency of cis eQTLs was
slightly higher in females than in males, which might be partly
explained by a higher rate of false positives due to the less stringent
statistical threshold applied to females to be comparable to males.
Due to the large number of cis SNPs per gene and the great power of
the present study for identifying cis eQTLs [13], it is unlikely that we
missed important X-linked cis eQTLs in monocytes. However, the true
magnitude of eQTLsmight be underestimated if the causal variant was
not directly genotyped but was in linkage disequilibrium with SNPs
on the array.
Four cis eQTLs, ARSD, DCX, POLA1 and ITM2A, exhibited a signiﬁcant
heterogeneity between sexes, all four having a stronger effect in
females. Notably, ARSD and ITM2A were among the 54 female-biased
genes detected in the present study and previously reported as
escaping XCI [5]. For these genes, the stronger genetic effect in
females might result from a partial or complete activation of the allele
carried by the chromosome escaping XCI. The ARSD gene belongs to a
cluster of sulfatase genes that is involved in chondrodysplasia
punctata (CDPX), a severe X-linked skeletal dysplasia [23]. These
sulfatase genes are also suspected to be involved in the metabolism of
warfarin, an anticoagulant widely used for preventing thrombosis
[23]. Interestingly, ARSD has been recently shown to belong to a
network of genes trans-regulated by the maternally imprinted KFL14
locus [24]. Parental imprinting might then be an alternative
explanation to the differential genetic effect observed between
males and females. Functional assays are required to investigate the
potential mechanisms at the origin of this difference.
The DCX gene belongs to a superfamily of proteins involved in
signal transduction and cytoskeletal regulation [25] and is responsiblefor defects in neuronal migration [26] and associated diseases such as
subcortical laminar heteropia (SCLH) [27] or chronic refractory
temporal lobe epilepsy [28]. Little is known about the POLA1 and
ITM2A genes, although the latter one has been suggestively associated
with height in a meta-analysis [29].
The present ﬁndings open new perspectives of research, such as
investigating the sex differences in other tissues, conﬁrming by
appropriate cell-hybrid functional assays that some of the newly
identiﬁed sex-biased genes do escape XCI and determining whether
sex differences in expression levels translate at the protein level. The
sex-biased genes identiﬁed in monocytes provide a source of
candidate genes to explain differences for phenotypic traits and
susceptibility to disease between males and females, and among
females that are heterogeneous with respect to X inactivation. Finally,
the X-linked cis eQTLs identiﬁed here provide a list of genes whose
expression may mediate the association between X-linked suscepti-
bility loci and disease.
4. Conclusions
This study suggests that escape from XCI may be more frequent
than previously estimated from population studies and may contrib-
ute to phenotypic differences between sexes. We also showed that for
the majority of X-linked genes, the impact of genetic variability on cis
regulation of expression was not substantially different between
sexes, with a few exceptions which might be clinically meaningful.
Finally, we indicate how to appropriately correct for the difference of
genetic variability explained by SNPs in the comparison of phenotypic
effects between sexes.
5. Subjects and methods
The study has been described in details elsewhere [13].
5.1. Study population
Study participants of both sexes aged 35–74 years were succes-
sively enrolled into the Gutenberg Heart Study (GHS), a community-
based cohort study based in the Rhein-Main region in western mid-
Germany. All subjects were of European origin and gave written
informed consent. Ethical approval was given by the local ethics
committee and by the local and federal data safety commissioners.
Individuals for whom we found a discrepancy between the pheno-
typic gender and the sex inferred from expression of Y-linked
transcripts were excluded, leaving 1467 individuals for analysis.
5.2. Genome-wide expression
Separation of monocytes was conducted within 60 min after blood
collection by negative selection using RosetteSep Monocyte Enrich-
ment Cocktail (StemCell Technologies, Vancouver, Canada). Total RNA
was extracted the same day using Trizol extraction and puriﬁcation by
silica-based columns. Expression proﬁles were assessed using the
Illumina HT-12 v3 BeadChip. Data were normalized using VST
transformation and quantile normalization as implemented in the
lumi R package [30,31]. Only probes with a “perfect” or “good”match
according to ReMOAT [32] were selected and probes with an
unknown or ambiguous chromosomal position were discarded,
leaving 1156 probes on the X chromosome. Of these, we selected
probes that had a detection p-valueb0.05 in ≥5% of males or ≥5% of
females (n=715).
5.3. Genome-wide genotyping
Genotyping was performed using the Affymetrix Genome-Wide
Human SNP Array 6.0 and the Genome-Wide Human SNP NspI/StyI 5.0
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calling algorithm and quality control was performed [33]. SNPs with a
minor allele frequencyb0.01 or deviating from Hardy–Weinberg
equilibrium (pb10−4) were excluded.
5.4. Statistical analysis
Analysis was performed at the probe level. Difference of mean
expression levels between males and females was tested by t-test
with sex-speciﬁc variances. A Bonferroni threshold was used to
correct for the number of probes tested (pb7×10−5). To test whether
the proportion of sex-biased transcripts on the X chromosome
signiﬁcantly differed from that on autosomes, we randomly re-
sampled 106 sets of 715 autosomal transcripts and assessed the
proportion of these in which the proportion of sex-biased transcripts
was higher than the one observed on the X chromosome.
Contamination of the samples by RNA derived from other blood
cell types than monocytes was assessed by estimating the
proportion of each cellular type using the deconvolution algorithm
proposed by Abbas et al. [15]. To estimate the expression proﬁles
characterizing the speciﬁc blood lineages, we used the publicly
available HaemAtlas dataset [16]. Applying this method, we found
that the samples contained an average of 83.4% of monocyte RNA
(95% coverage interval [69.9–93.4]). Other cell types included
platelets, T lymphocytes and Natural Killer cells, B lymphocytes
(~5% each) and traces of RNA from erythrocytes and granulocytes
(b 2%). Differences of expression according to sex were re-tested
after adjustment on the proportions of the different cell types
estimated for each individual.
Sex difference of X-linked gene expression was further tested after
exclusion of women with oral contraception (n=52) or women with
hormone replacement therapy (n=79), and after adjustment for age,
body mass index and smoking status (smoker vs non-smoker).
For the analysis of cis eQTLs, all SNPs located within 250 kb of
either the transcription starting site (TSS) or the transcription ending
site (TES) of any X-linked transcript were selected (15,703 cis SNPs).
Probes with a SNP within their sequence were excluded from this
analysis to avoid any bias due to a difference of binding between the
probe and its transcript.
Association between expression and SNP was tested by linear
regression model with genotype coded (0, 2) in males and (0, 1, 2) in
females according to the number of minor alleles. Thismodel assumed
additive allele effects. Departure from additivity was tested in females
by comparing the additive model to the general model (χ2 with 1 df).
For every expression trait, a p-value of association was computed for
each cis SNP-transcript pair, separately in males and females. We
focused on cis eQTLs explaining N5% of expression variability in either
males or females. In females, the genetic R2 was corrected to account
for the difference of genetic variance between sexes and make the R2
statistics comparable between males and females (see Appendix).
Homogeneity of allele effects between males and females was tested
by introducing a sex×genotype interaction in the linear regression
model, with genotype coded as outlined above. We computed a
combined p-value for males and females using Fisher's method and
selected for each expression trait the SNP–transcript pair with the
lowest combined p-value.
All analyses were performed in R v. 2.12.0 [34].
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Appendix A. Comparison of the genetic R2 in females and males for
X-linked SNPs
We consider an X-linked SNP with allele effect β on expression. The
allele effect is assumed to be equal inmales and in females. If the gene is
submitted to XCI, female homozygotes are expected to have the same
expression level as male hemizygotes while female heterozygotes have
a level increased by β/2 by comparison to reference homozygotes since
half of their cells carry an active allele and half carry an inactive allele.
The genetic variance explained by the SNP is therefore twice higher in
males than in females, that is VXM=2VXF where VXM is the genetic
variance in males and VXF is the genetic variance in females.
If the residual variance Vres is the same in both sexes, we have:
R2XM = VXM = VXM + Vresð Þ = 2VXF = 2VXF + Vresð Þ and
R2XF = VXF = VXF + Vresð Þ
where R2XM is the proportion of variance of expression explained by
the X-linked SNP in males and R2XF is the proportion in females. From
these formulae we can deduce that R2XM=2 R2XF/(R2XF+1).
For purpose of comparison between males and females, R2XF was
then multiplied by a correction factor equal to 2/(R2XF+1).
Appendix B. Supplementary data
Supplementary data to this article can be found online at doi:10.
1016/j.ygeno.2011.06.009.References
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